Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: LUMOS DIAGNOSTICS, INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-09-25 to 2026-08-31
Current total value of award: $2984571
Description: EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX    RESPONSE TO BAA-23-100-SOL-00004